petosemtamab
merus
['petosemtamab', 'merus ']
we are proud to present interim clinical data this morning at #aacr23 showing that petosemtamab demonstrates clinically meaningful activity in previously treated #hnscc #closeinoncancer 
Clinical-stage oncology company developing Biclonics® bispecific antibody therapeutics. Please see our Community Guidelines: https://t.co/qN9crK04bE